Growth financing XAnge is a €800 million early-stage fund actively investing across Seed to Series C, presenting a strong opportunity to target portfolio companies or prospective deals at multiple growth inflection points with investment syndication or co-leading rounds.

Tech focus Their focus on Deep Tech, AI, SaaS, energy transition, digital finance and healthcare indicates high readiness to engage with startups leveraging advanced technology, making a favorable channel for partnerships, pilots, and strategic co-investments.

Geographic reach With offices in Paris, Berlin, and Brussels and a Europe-centric portfolio, there is potential to approach regional founders and leverage cross-border introductions, as well as sell services tailored to European market expansion and regulatory navigation.

Sustainability As a BCorp-certified investor, XAnge emphasizes responsible business practices, presenting a value proposition for startups aiming to align with ESG goals, customer sustainability requirements, and impact-driven partnerships.

Active exits and deals Recent and ongoing investments in AI, deep tech and healthcare (e.g., Tomorro, Diagnoly, Homaio, Popsink) show a tempo of activity and appetite for follow-on rounds, suggesting opportunities for multi-stage engagement, co-investing, and syndicated rounds.